Physician profile
John H Moore
NPI 1851343040
$1,311.94
in general payments reported to CMS, 2019-2025
30 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $663 · 2020: $102 · 2022: $269 · 2023: $277.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $277.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $276.68 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $401.45 | 2019-2023 | |
| Astellas Pharma US INC | $99.61 | 2019-2023 | Veozah |
| Lupin INC. | $72.69 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $71.48 | 2020-2023 | |
| Novo Nordisk INC | $67.50 | 2019-2023 | Wegovy |
| Daiichi Sankyo INC. | $52.91 | 2019-2023 | Injectafer |
| Pfizer INC. | $51.51 | 2019-2022 | |
| Amgen INC. | $50.89 | 2019 | |
| Duchesnay USA Incorporated | $45.71 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $39.28 | 2019-2020 | |
| Therapeuticsmd, INC. | $37.37 | 2019-2020 | |
| Amag Pharmaceuticals, INC. | $36.78 | 2019 | |
| Mylan Pharmaceuticals INC. | $32.88 | 2022 | |
| Meditrina | $28.70 | 2023 | |
| Shield Therapeutics INC | $23.58 | 2022 |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Agile Therapeutics, INC. | $20.84 | 2023 | Twirla |
| Exact Sciences Corporation | $16.09 | 2023 | Cologuard Collection Kit |
| Exeltis, USA INC. | $15.83 | 2022 | |
| Aspira Women'S Health INC | $15.36 | 2023 | Ova1 |
| Millicent US INC | $13.37 | 2019 | |
| Scynexis, INC. | $12.99 | 2022 | |
| Gilead Sciences, INC. | $12.85 | 2019 | |
| Evofem Biosciences, INC. | $12.51 | 2022 | |
| Coloplast Corp | $12.48 | 2019 | |
| Coopersurgical, INC. | $12.12 | 2019 | |
| Avion Pharmaceuticals | $11.74 | 2019 | |
| Hologic Sales and Service, LLC | $11.43 | 2019 | |
| Currax Pharmaceuticals LLC | $11.35 | 2019 | |
| Merck Sharp & Dohme LLC | $10.90 | 2019 | |
| Allergan, INC. | $9.74 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Moore listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.